Introducing Medicare Drug Focus: Weekly Business Intelligence for the Emerging Medicare Drug Marketplace.
Posted on: Monday, 19 September 2005, 12:00 CDT
F-D-C Reports, Inc., publisher of "The Pink Sheet," announced today the launch of Medicare Drug Focus, a weekly news publication for Medicare prescription drug plan stakeholders. F-D-C created this new service to provide pharmaceutical and health plan executives with the information they need to succeed in the rapidly changing Medicare drug marketplace.
"Recognizing the broad implications of the Medicare Rx drug benefit, we assembled a team of veteran healthcare journalists from across F-D-C Reports to develop and staff Medicare Drug Focus. We anticipate this online weekly will become a must-read for pharma and health plan leaders who face the complex implementation of Medicare's new programs," says F-D-C President Mike Squires.
The Centers for Medicare & Medicaid Services is making its final push toward implementing the Part D prescription drug benefit. Participating drug plan sponsors will be announced this week, marketing begins Oct. 1 and the benefit will commence on Jan. 1.
With Medicare Drug Focus, stakeholders can confidently stay on top of these milestones. Readers will be fully cognizant of future changes to Medicare drug policy, understand the nuances and implications of these changes, and learn the strategies pharma/biotech companies and health plans are implementing in response. In addition, key business developments involving participating Part D insurers, PBMs and pharma manufacturers will be closely covered, as will marketing and outreach efforts, plan formularies, legislative developments and compliance programs.
To register for a 30-day, risk-free trial, please visit www.MedicareDrugFocus.com.
Every Monday, Medicare Drug Focus will deliver a blend of timely, objective, balanced news and special in-depth features designed to provide a comprehensive perspective on the Medicare drug benefit. When important news occurs mid-week, the Medicare Drug Focus staff will keep you up to date with breaking news alerts. With accompanying Facts & Figures slides, a searchable archives, topical story index, calendar of Medicare drug benefit events and more, the Medicare Drug Focus website will keep you covered.
For more information, or to sign up for a 30-day, risk-free trial, please go to www.MedicareDrugFocus.com or call F-D-C's Customer Service team at 800-332-2181.
About F-D-C Reports
F-D-C Reports provides up-to-date information about the worldwide health care industry via its publications including The Pink Sheet(R), The Gray Sheet(R), The Rose Sheet(R), The Tan Sheet(R), Research Policy Alert, and Pharmaceutical Approvals Monthly. The publications are read extensively by pharmaceutical and healthcare executives, policy-makers, and analysts seeking to understand the developments affecting the U.S. regulation and marketing of healthcare products and services. F-D-C Reports has one of the largest, most experienced, and most respected editorial teams reporting on the latest regulatory, legislative, and business news affecting the U.S. drug, biotechnology, medical device, nonprescription drug, nutritionals, and cosmetics industries.
F-D-C Reports, Inc. is part of Elsevier. Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, the company publishes more than 1,800 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products and online reference works. For more information, visit www.elsevier.com.
Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). For more information, visit www.reedelsevier.com.
Source: Business Wire
Related Articles
- Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC
- Health Plans Highlight Value of Medicare Advantage Special Needs Plans
- Senior Whole Health Expands Medicare Advantage Special Needs Plan Coverage Area to Include Fairfield County, Conn.
- 'Womens Health - Contraception Drug Pipeline Report' Contains Detailed Information On The Current Drug Pipeline
- 'Womens Health - Female Sexual Dysfunction Drug Pipeline Report' Contains Detailed Information on the Current Drug Pipeline
- Research and Markets: Women's Health - Infertility Drug Pipeline Report
- General Satisfaction With Plan Benefits Found Among Patients Navigating Medicare Part D, According to Study By GfK Market Measures
- Aveta Health Illinois Launches Medicare Advantage Special Needs Plans for the Chronically Ill in Cook County
- Firms Drop Drug Coverage, Force Medicare Enrollees to Join Plans
- WHO Report Focuses on Bettering Health Systems
 |
 |
User Comments (0)
RSS Feeds